Regina Brown - 30 Jun 2022 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Regina Brown
Issuer symbol
LIXT
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Aug 2022, 16:43:50 UTC
Previous filing
02 Jul 2021
Next filing
22 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Options to Purchase Common Stock Award $0 +100,000 $0.000000 100,000 30 Jun 2022 Common 100,000 $0.7446 Direct F1
holding LIXT Options to Purchase Common Stock 100,000 30 Jun 2022 Common 100,000 $3.03 Direct
holding LIXT Options to Purchase Common Stock 250,000 30 Jun 2022 Common 250,000 $2.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 30, 2022, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2022).